The Evaluation of Serum Endocan, Interleukin-6, and CRP Levels Following Sleeve Gastrectomy

References

• Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17(1):4–12.
   PubMed Web of Science ®Google Scholar
• Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316(2):129–139. doi:10.1016/j.mce.2009.08.018
   PubMed Web of Science ®Google Scholar
• Sam S, Mazzone T. Adipose tissue changes in obesity and the impact on metabolic function. Transl Res. 2014;164(4):284–292. doi:10.1016/j.trsl.2014.05.008
   PubMed Web of Science ®Google Scholar
• Alessi MC, Bastelica D, Morange P, et al. Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes. 2000;49(8):1374–1380. doi:10.2337/diabetes.49.8.1374
   PubMed Web of Science ®Google Scholar
• van Dielen FM, Van’t Veer C, Schols AM, Soeters PB, Buurman WA, Greve JW. Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obes Relat Metab Disord. 2001;25(12):1759–1766. doi:10.1038/sj.ijo.0801825
   PubMed Web of Science ®Google Scholar
• Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery [published correction appears in Obes Surg. 2022 Nov 29]. Obes Surg. 2023;33(1):3–14. doi:10.1007/s11695-022-06332-1
   PubMed Web of Science ®Google Scholar
• Schlottmann F, Galvarini MM, Dreifuss NH, Laxague F, Buxhoeveden R, Gorodner V. Metabolic effects of bariatric surgery. J Laparoendosc Adv Surg Tech A. 2018;28(8):944–948. doi:10.1089/lap.2018.0394
   PubMed Web of Science ®Google Scholar
• Dixon JB. Surgical management of obesity in patients with morbid obesity and nonalcoholic fatty liver disease. Clin Liver Dis. 2014;18(1):129–146. doi:10.1016/j.cld.2013.09.011
   PubMed Web of Science ®Google Scholar
• Monte SV, Caruana JA, Ghanim H, et al. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus. Surgery. 2012;151(4):587–593. doi:10.1016/j.surg.2011.09.038
   PubMed Web of Science ®Google Scholar
• Vilarrasa N, Vendrell J, Sánchez-Santos R, et al. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients. Clin Endocrinol. 2007;67(5):679–686. doi:10.1111/j.1365-2265.2007.02945.x
   PubMed Web of Science ®Google Scholar
• Illán-Gómez F, Gonzálvez-Ortega M, Orea-Soler I, et al. Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery. Obes Surg. 2012;22(6):950–955. doi:10.1007/s11695-012-0643-y
   PubMed Web of Science ®Google Scholar
• Holdstock C, Lind L, Engstrom BE, et al. CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects. Int J Obes. 2005;29(10):1275–1280. doi:10.1038/sj.ijo.0803000
   PubMed Web of Science ®Google Scholar
• Shih KC, Janckila AJ, Lee WJ, et al. Effects of bariatric weight loss surgery on glucose metabolism, inflammatory cytokines, and serum tartrate-resistant acid phosphatase 5a in obese Chinese adults. Clin Chim Acta. 2016;453:197–202. doi:10.1016/j.cca.2015.11.004
   PubMed Web of Science ®Google Scholar
• Biobaku F, Ghanim H, Monte SV, Caruana JA, Dandona P. Bariatric surgery: remission of inflammation, cardiometabolic benefits, and common adverse effects. J Endocr Soc. 2020;4(9):bvaa049. doi:10.1210/jendso/bvaa049
   PubMed Web of Science ®Google Scholar
• Janke J, Engeli S, Gorzelniak K, et al. Adipose tissue and circulating endothelial cell specific molecule-1 in human obesity. Horm Metab Res. 2006;38(1):28–33. doi:10.1055/s-2006-924973
   PubMed Web of Science ®Google Scholar
• Rodrigues KF, Pietrani NT, Bosco AA, et al. Endocan: a new biomarker associated with inflammation in type 2 diabetes mellitus? Diabetes Metab Res Rev. 2015;31(5):479–480. doi:10.1002/dmrr.2639
   PubMed Web of Science ®Google Scholar
• Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther. 2006;8 Suppl 2(Suppl 2):S3. doi:10.1186/ar1917
   PubMedGoogle Scholar
• Casimiro I, Hanlon EC, White J, et al. Reduction of IL-6 gene expression in human adipose tissue after sleeve gastrectomy surgery. Obes Sci Pract. 2020;6(2):215–224. doi:10.1002/osp4.396
   PubMed Web of Science ®Google Scholar
• Schernthaner GH, Kopp HP, Kriwanek S, et al. Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity. Obes Surg. 2006;16(6):709–715. doi:10.1381/096089206777346763
   PubMed Web of Science ®Google Scholar
• Christiansen T, Richelsen B, Bruun JM. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond). 2005;29(1):146–150. doi:10.1038/sj.ijo.0802839
   PubMed Web of Science ®Google Scholar
• Ni Y, Zhao L, Yu H, et al. Circulating unsaturated fatty acids delineate the metabolic status of obese individuals. E Bio Medicine. 2015;2(10):1513–1522.
   Google Scholar
• Kim CS, Park HS, Kawada T, et al. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes (Lond). 2006;30(9):1347–1355. doi:10.1038/sj.ijo.0803259
   PubMed Web of Science ®Google Scholar
• Lasselin J, Magne E, Beau C, et al. Adipose inflammation in obesity: relationship with circulating levels of inflammatory markers and association with surgery-induced weight loss. J Clin Endocrinol Metab. 2014;99(1):E53–61. doi:10.1210/jc.2013-2673
   PubMed Web of Science ®Google Scholar
• Sarrazin S, Lyon M, Deakin JA, et al. Characterization and binding activity of the chondroitin/dermatan sulfate chain from Endocan, a soluble endothelial proteoglycan. Glycobiology. 2010;20(11):1380–1388. doi:10.1093/glycob/cwq100
   PubMed Web of Science ®Google Scholar
• Kali A, Shetty KS. Endocan: a novel circulating proteoglycan. Indian J Pharmacol. 2014;46(6):579–583. doi:10.4103/0253-7613.144891
   PubMed Web of Science ®Google Scholar
• Béchard D, Scherpereel A, Hammad H, et al. Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1. J Immunol. 2001;167(6):3099–3106. doi:10.4049/jimmunol.167.6.3099
   PubMed Web of Science ®Google Scholar
• Gaudet A, Portier L, Mathieu D, et al. Cleaved endocan acts as a biologic competitor of endocan in the control of ICAM-1-dependent leukocyte diapedesis. J Leukoc Biol. 2020;107(5):833–841. doi:10.1002/JLB.3AB0320-612RR
   PubMed Web of Science ®Google Scholar
• Delibas IB, Yapca OE, Laloglu E. Does endocan level increase in women with polycystic ovary syndrome? A case - control study. Ginekol Pol. 2018;89(9):500–505. doi:10.5603/GP.a2018.0085
   PubMed Web of Science ®Google Scholar
• Elkamshoushi AM, Omar SS, El Abd AM, Hassan SZ, Sultan EA, Abd Elkawy E. Subclinical atherosclerosis in psoriatic disease: relation to endocan, TNF-α, age of onset, and body fat. Int J Dermatol. 2019;58(4):456–464. doi:10.1111/ijd.14290
   PubMed Web of Science ®Google Scholar
• Bicer M, Guler A, Unal Kocabas G, et al. Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome. Endocr Res. 2017;42(2):145–153. doi:10.1080/07435800.2016.1255896
   PubMed Web of Science ®Google Scholar
• Fenske WK, Dubb S, Bueter M, et al. Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study. Surg Obes Relat Dis. 2013;9(4):559–568. doi:10.1016/j.soard.2012.03.009
   PubMed Web of Science ®Google Scholar
• Lautenbach A, Stoll F, Mann O, et al. Long-term improvement of chronic low-grade inflammation after bariatric surgery. Obes Surg. 2021;31(7):2913–2920. doi:10.1007/s11695-021-05315-y
   PubMed Web of Science ®Google Scholar
• Chiappetta S, Schaack HM, Wölnerhannsen B, Stier C, Squillante S, Weiner RA. The impact of obesity and metabolic surgery on chronic inflammation [published correction appears in Obes Surg. 2018 Jun 27]. Obes Surg. 2018;28(10):3028–3040. doi:10.1007/s11695-018-3320-y
   PubMedGoogle Scholar
• Schauer DP, Arterburn DE, Livingston EH, et al. Impact of bariatric surgery on life expectancy in severely obese patients with diabetes: a decision analysis. Ann Surg. 2015;261(5):914–919. doi:10.1097/SLA.0000000000000907
   PubMed Web of Science ®Google Scholar
• Migliore E, Brunani A, Ciccone G, et al. Effect of bariatric surgery on survival and hospitalizations in patients with severe obesity. A retrospective cohort study. Nutrients. 2021;13(9):3150. doi:10.3390/nu13093150
   PubMed Web of Science ®Google Scholar